Basic Information
illumigyn was founded in Israel in 2012 and has quickly grown into a multidisciplinary team comprising healthcare professionals, management, and business development experts. Our Scientific Advisory Board is an independent group of thought leaders who share our commitment to creating a world free of cervical cancer. Illumigyn integrates existing machine vision technology into compact imaging colposcopes for medical applications to eliminate the inherent subjectivity in cervical examinations. Its Gynescope is a patented imaging colposcope that provides 15-micron image resolution across a wide field of view and a range of working distances. The Gynescope also features multispectral illumination options, enabling the detection of early-stage cervical cancer while reducing misdiagnosis. The Gynescope facilitates complex imaging and simultaneous intricate interventional procedures to support optimal clinical outcomes.